A combination of myokines and genistein suppresses cancer stemness in MCF-7 human breast cancer cells.

Published in: Nutrition research and practice (2024)

These results suggested that combining Iri or OSM with Gen has an additive effect on breast CSCs by regulating self-renewal capacity and expression of CSCs markers. Therefore, the combination of myokines and Gen may have the therapeutic potential for treating breast cancer and improving the quality of life of cancer patients.

Keyphrases

breast cancer cells
cancer stem cells
endothelial cells
poor prognosis
papillary thyroid
stem cells
epithelial mesenchymal transition
pluripotent stem cells
squamous cell carcinoma